Promote Inhaler Safety and Adherence During Care Transitions

February 2021

This complimentary article from Hospital Pharmacist’s Letter is being provided to readers of Prescriber’s Letter, who may find its content relevant to their practice.

You can help limit inhaler errors during transitions of care.

Document med histories carefully. For example, there are over 500 errors reported for Ellipta inhaler devices...since different meds have similar names (Anoro Ellipta, Breo Ellipta, etc).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

COVID-19 Guide Use of mRNA COVID-19 Vaccines for Special Populations
COVID-19 Know the Ins and Outs of Giving mRNA COVID-19 Vaccines
STIs Shift to Treating Gonorrhea With Just Ceftriaxone
Heart Failure Don’t Jump to Spironolactone or Entresto for HFpEF
COVID-19 Limit Use of Unproven Outpatient Treatments for COVID-19
COVID-19 Point Out Pros and Cons of the Ellume COVID-19 Home Test
Hormone Therapy Be Familiar With Hormone Therapies for Transgender Patients
Gastroenterology Evaluate Appropriate Use of Pancreatic Enzymes
Acne Understand the Role of Winlevi for Acne
Critical Care Have a Plan When ICU Patients Require High Sedative Doses
Inhalers Promote Inhaler Safety and Adherence During Care Transitions

Promote Inhaler Safety and Adherence During Care Transitions

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents